Home › NDC Lookup › RxCUI directory › RxCUI 863042

Bepotastine besilate 15 MG/ML Ophthalmic Solution [Bepreve] — RxCUI 863042

RxNorm drug concept · Semantic branded drug
RxCUI 863042 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI863042
Official nameBepotastine besilate 15 MG/ML Ophthalmic Solution [Bepreve]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asBepreve 1.5 % Ophthalmic Solution; Bepreve 15 MG/ML Ophthalmic Solution
FDA products mapped1
Package NDCs mapped3
Reported Medicaid activity (SDUD)1,403 prescriptions · 10 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Bepotastine Ophthalmic: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It's designed to stop the itching that comes with eye allergies — what doctors call allergic conjunctivitis. It works by blocking histamine, the chemical your immune system release...
  • What exactly is this eye drop supposed to do?
  • That mild taste after instillation is actually the most common side effect — about 1 in 4 people notice it. It happens because a tiny amount of the drop drains from the eye into th...
  • Why do I taste something weird after I put in the drops?
📖 Read our full Bepotastine Ophthalmic guide →

🕸️ Concept Web — How Bepotastine besilate 15 MG/ML Ophthalmic Solutio... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Bepotastine besilate 15 MG/ML Ophthalmic Solution [Bepreve] RxCUI 863042

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Bepotastine 863035
    • Bepotastine besilate 658552
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Bepreve 863039
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Bepotastine Ophthalmic Solution 863037
    • Bepotastine besilate Ophthalmic Solution 2645835
    • Bepotastine Ophthalmic Product 1160554
    • Bepotastine besilate Ophthalmic Product 2659541
    • Bepotastine Ophthalmic Solution [Bepreve] 863041
    • Bepotastine besilate Ophthalmic Solution [Bepreve] 2657588
    • Bepreve Ophthalmic Product 1172208
    • Ophthalmic Solution 7670
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Bepotastine besilate 15 MG/ML Ophthalmic Solution SCD · 863038
  • Bepotastine besilate 15 MG/ML SCDC · 863036
  • Bepotastine Ophthalmic Solution SCDF · 863037
  • Bepotastine besilate Ophthalmic Solution SCDFP · 2645835
  • Bepotastine Ophthalmic Product SCDG · 1160554
  • Bepotastine besilate Ophthalmic Product SCDGP · 2659541

Brand-Name Concepts

  • Bepotastine besilate 15 MG/ML [Bepreve] SBDC · 863040
  • Bepotastine Ophthalmic Solution [Bepreve] SBDF · 863041
  • Bepotastine besilate Ophthalmic Solution [Bepreve] SBDFP · 2657588
  • Bepreve Ophthalmic Product SBDG · 1172208
  • Bepreve BN · 863039

📦 FDA Products & Package NDCs

1 product · 3 package NDCs
3 package NDCs map to RxCUI 863042 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
24208-0629-01 1 BOTTLE, DROPPER in 1 CARTON (24208-629-01) / 10 mL in 1 B... Bepreve Bausch & Lomb Incorporated 2009-09-08
24208-0629-02 1 BOTTLE, DROPPER in 1 CARTON (24208-629-02) / 5 mL in 1 BO... Bepreve Bausch & Lomb Incorporated 2009-09-08
24208-0629-03 1 BOTTLE, DROPPER in 1 CARTON (24208-629-03) / 1 mL in 1 BO... Bepreve Bausch & Lomb Incorporated 2009-09-08
Observed labelers: Bausch & Lomb Incorporated (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$54.8734
Range $53.8111–$55.9357 · middle 50% $54.3423–$55.4046 · 2 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.